Miniature Active Implants – The Key Area for Innovation in Next-Generation Drug Delivery

3/21/2022 14:30 - 15:00

Cambridge Consultants' Harshal Shah, head of global BioPharma medical technology presents on how miniature active implants are a key area for innovation in next-generation drug delivery.

Innovation in drug delivery devices has evolved at a constant pace for 30 years, improving outcomes with better delivery of lifesaving drugs. Now, we’re entering a new era – as we look forward to a decade of innovation and commercial opportunity in active implants.

Harshal Shah, Head of Global BioPharma Commercial, Cambridge Consultants